Expertise in
80
conditions

Dr. Majd Chahin

Hematology
South Carolina Cancer Specialist P.A.
100 Buckwalter Place Blvd Ste 130, 
Bluffton, SC 
Expertise in
80
conditions
South Carolina Cancer Specialist P.A.
100 Buckwalter Place Blvd Ste 130, 
Bluffton, SC 

Overview

Majd Chahin is a Hematologist practicing medicine in Bluffton, South Carolina.

Dr. Chahin is highly rated in 80 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Paget Disease of the Breast, Breast Cancer, and Colorectal Cancer.

He is actively involved in clinical research, participating in 8 clinical trials.

Specialties

Hematology

Licenses

Internal Medicine in SC

Hospital Affiliations

Musc Health Marion Medical Center
Candler Hospital
Musc Medical Center
Musc Health Florence Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

South Carolina Cancer Specialist P.A.
100 Buckwalter Place Blvd Ste 130, Bluffton, SC 29910

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer
Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
Intervention Type: Other, Procedure, Drug, Biological
Study Phase: Phase 3
A Phase II Trial of Trametinib With Docetaxel in Patients With KRAS Mutation Positive Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease Following One or Two Prior Systemic Therapies
A Phase II Trial of Trametinib With Docetaxel in Patients With KRAS Mutation Positive Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease Following One or Two Prior Systemic Therapies
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2026
Intervention Type: Other, Drug
Study Drugs: Docetaxel, Trametinib
Study Phase: Phase 2
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 10, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
The National Myelodysplastic Syndromes Natural History Study
The National Myelodysplastic Syndromes Natural History Study
Enrollment Status: Completed
Publish Date: February 03, 2026
Intervention Type: Other
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Other
Study Phase: Phase 3
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
Implementation of a Prospective Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
Implementation of a Prospective Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: January 26, 2023
Intervention Type: Other
View 7 Less Clinical Trials
Similar Doctors
Expertise in
99
conditions
Dr. Gary Thomas
Hematology | Oncology
Expertise in
99
conditions
Dr. Gary Thomas
Hematology | Oncology
Referral may be required

Sc Cancer Specialists-Hilton Head At St. Joseph's/Candler

45 Hospital Center Cmns, 
Hilton Head Island, SC 
 (144.8 miles away)
843-689-2895
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gary Thomas is a Hematologist and an Oncologist practicing medicine in Hilton Head Island, South Carolina. Dr. Thomas is highly rated in 99 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome.

Expertise in
77
conditions
Dr. Mark Taylor
Hematology
Expertise in
77
conditions
Dr. Mark Taylor
Hematology
Referral may be required

Summit Cancer Care, PC

225 Candler Dr Ste 300, 
Savannah, GA 
 (168.2 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Taylor is a Hematologist practicing medicine in Savannah, Georgia. Dr. Taylor is highly rated in 77 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Lung Cancer, Intraductal Papilloma, and Bone Marrow Aspiration. Dr. Taylor is currently accepting new patients.

Expertise in
94
conditions
Expertise in
94
conditions
Referral may be required

Summit Cancer Care At Anderson Care Institute

4700 Waters Ave Ste A, 
Savannah, GA 
 (163.9 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ronald Goldberg is a Hematologist practicing medicine in Savannah, Georgia. Dr. Goldberg is highly rated in 94 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Goldberg is currently accepting new patients.

Frequently Asked Questions about Dr. Majd Chahin

How do I make an appointment with Dr. Majd Chahin?

You can book an appointment with Dr. Majd Chahin by calling their office at 843-836-7100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Majd Chahin a top-rated expert for Myelodysplastic Syndrome (MDS)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Majd Chahin is classified as an Distinguished expert for Myelodysplastic Syndrome (MDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Majd Chahin specialize in?

While Dr. Majd Chahin is a Hematology, they have specific expertise in Myelodysplastic Syndrome (MDS), Paget Disease of the Breast, and Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Majd Chahin accept my insurance?

Dr. Majd Chahin accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 843-836-7100 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chahin's expertise for a condition
ConditionClose
    View All 23 Distinguished Conditions
    View All 57 Advanced Conditions
    View All 155 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile